Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$6.28.

  • Jaguar Health's EPS (Basic) rose 7611.26% to -$6.28 in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.21, marking a year-over-year increase of 9950.37%. This contributed to the annual value of -$130.69 for FY2024, which is 9512.03% up from last year.
  • According to the latest figures from Q3 2025, Jaguar Health's EPS (Basic) is -$6.28, which was up 7611.26% from -$10.26 recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's EPS (Basic) registered a high of $0.44 during Q4 2022, and its lowest value of -$594.64 during Q4 2023.
  • In the last 5 years, Jaguar Health's EPS (Basic) had a median value of -$10.26 in 2025 and averaged -$51.23.
  • As far as peak fluctuations go, Jaguar Health's EPS (Basic) skyrocketed by 10050.37% in 2022, and later plummeted by 13524628.81% in 2023.
  • Jaguar Health's EPS (Basic) (Quarter) stood at -$87.35 in 2021, then soared by 100.5% to $0.44 in 2022, then tumbled by 135246.29% to -$594.64 in 2023, then soared by 94.16% to -$34.75 in 2024, then soared by 81.93% to -$6.28 in 2025.
  • Its EPS (Basic) stands at -$6.28 for Q3 2025, versus -$10.26 for Q2 2025 and -$16.7 for Q1 2025.